FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...
Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earnings
Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral ...
J&J’s ketamine-derived nasal spray approved by FDA to treat depression
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.
UVA Today1d
UVA Researchers To Test Ketamine’s Power To Stop Deadly Epilepsy Seizures
Researchers at the University of Virginia Brain Institute and UVA School of Medicine will conduct a trial to see if the ...
The Tab3d
Should ketamine become a Class A drug? Tell us how you feel about its potential reclassification here
So, the UK government is considering reclassing ketamine as a Class A drug. The Home Office asked the Advisory Council on the ...
Research indicates recreational ketamine use is on the rise
Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...
Daily Camera16h
Boulder Community Health now offering ketamine therapy, other therapies for treatment-resistant conditions
Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...
4 charged in major NYC ketamine drug trafficking bust dubbed ‘Operation Frostbite’
A massive drug bust in Flushing, Queens has led to the indictment of four individuals accused of running a dangerous ...
The FDA just approved this ketamine-derived nasal spray for depression treatment
The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...
Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...
WRIC on MSN18h
UVA researchers aim to stop deadly seizures with nationwide ketamine trial
The University of Virginia (UVA) is spearheading a nationwide clinical trial exploring a new treatment option for prolonged ...